Safety, Efficacy and Pharmacokinetics of ALD403
Safety Tolerability and Pharmacokinetics of ALD403
A Multicenter Assessment of ALD403 in Chronic Migraine
An Open Label Trial of ALD403 (Eptinezumab) in Chronic Migraine
Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine
|6||Active, not recruiting||
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
† Study has passed its completion date and status has not been verified in more than two years.